Nicolas Janus
83, Boulevard De L'Hôpital
Paris, 75013, France
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations.
Journal: International journal of clinical pharmacy
Published: July 06, 2023
Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study.
Journal: Journal de medecine vasculaire
Published: February 25, 2022
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 08, 2021
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
Journal: Cancers
Published: March 18, 2020
Non-iodinated contrast media nephrotoxicity
Journal: Nephrologie & therapeutique
Published: October 11, 2018
Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis.
Journal: Expert opinion on drug metabolism & toxicology
Published: May 25, 2017
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?
Journal: AIDS reviews
Published: July 21, 2016
Renal function and venous thromboembolic diseases.
Journal: Journal des maladies vasculaires
Published: March 18, 2016
Course of chronic kidney disease in French patients.
Journal: Clinical kidney journal
Published: January 15, 2016
Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists
Journal: Annales de biologie clinique
Published: December 05, 2015
Last Updated: 09/26/2026